Your browser doesn't support javascript.
loading
Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.
Zivadinov, R; Hojnacki, D; Bergsland, N; Kennedy, C; Hagemeier, J; Melia, R; Ramasamy, D P; Durfee, J; Carl, E; Dwyer, M G; Weinstock-Guttman, B.
Afiliação
  • Zivadinov R; Department of Neurology, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, NY, USA.
  • Hojnacki D; MR Imaging Clinical Translational Research Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
  • Bergsland N; Jacobs MS Center, Department of Neurology, University at Buffalo, State University of New York, Buffalo, NY, USA.
  • Kennedy C; Department of Neurology, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, NY, USA.
  • Hagemeier J; Magnetic Resonance Laboratory, IRCCS Don Gnocchi Foundation, Milan, Italy.
  • Melia R; Department of Neurology, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, NY, USA.
  • Ramasamy DP; Department of Neurology, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, NY, USA.
  • Durfee J; Department of Neurology, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, NY, USA.
  • Carl E; Department of Neurology, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, NY, USA.
  • Dwyer MG; Department of Neurology, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, NY, USA.
  • Weinstock-Guttman B; Department of Neurology, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, NY, USA.
Eur J Neurol ; 23(6): 1101-9, 2016 06.
Article em En | MEDLINE | ID: mdl-26998905

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Esclerose Múltipla Recidivante-Remitente / Natalizumab / Fatores Imunológicos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Esclerose Múltipla Recidivante-Remitente / Natalizumab / Fatores Imunológicos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article